Pharming Group NV (PHAR)
9.68
-0.12
(-1.22%)
USD |
NASDAQ |
Oct 06, 16:00
Pharming Group Price : 9.68 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 9.86 | 9.86 | 9.68 | 9.68 | 6726.00 |
| Oct 05, 2026 | 9.75 | 10.08 | 9.736 | 9.80 | 10814.00 |
| Oct 02, 2026 | 9.95 | 9.959 | 9.75 | 9.75 | 12408.00 |
| Oct 01, 2026 | 10.08 | 10.15 | 9.95 | 9.95 | 12090.00 |
| Sep 30, 2026 | 10.16 | 10.28 | 9.99 | 9.99 | 12321.00 |
| Sep 29, 2026 | 10.17 | 10.23 | 10.00 | 10.01 | 26268.00 |
| Sep 28, 2026 | 10.46 | 10.70 | 10.33 | 10.52 | 15477.00 |
| Sep 25, 2026 | 10.42 | 11.15 | 10.25 | 10.46 | 128548.0 |
| Sep 24, 2026 | 10.59 | 10.64 | 10.36 | 10.44 | 31867.00 |
| Sep 23, 2026 | 11.00 | 11.06 | 10.65 | 10.77 | 28598.00 |
| Sep 22, 2026 | 11.11 | 11.48 | 10.99 | 11.26 | 51291.00 |
| Sep 21, 2026 | 10.50 | 11.50 | 10.50 | 10.81 | 218384.0 |
| Sep 18, 2026 | 10.72 | 10.75 | 10.50 | 10.55 | 7853.00 |
| Sep 17, 2026 | 10.73 | 10.94 | 10.73 | 10.78 | 5400.00 |
| Sep 16, 2026 | 10.67 | 10.75 | 10.50 | 10.60 | 58027.00 |
| Sep 15, 2026 | 10.82 | 10.83 | 10.44 | 10.55 | 15274.00 |
| Sep 14, 2026 | 10.78 | 11.19 | 10.72 | 10.82 | 19681.00 |
| Sep 11, 2026 | 10.82 | 11.69 | 10.65 | 11.21 | 39069.00 |
| Sep 10, 2026 | 10.91 | 10.97 | 10.67 | 10.80 | 15338.00 |
| Sep 09, 2026 | 11.15 | 11.54 | 10.97 | 10.97 | 12133.00 |
| Sep 08, 2026 | 11.38 | 11.50 | 11.30 | 11.50 | 21512.00 |
| Sep 04, 2026 | 11.16 | 11.54 | 11.16 | 11.23 | 5544.00 |
| Sep 03, 2026 | 11.38 | 11.48 | 11.30 | 11.46 | 5350.00 |
| Sep 02, 2026 | 11.51 | 11.55 | 11.20 | 11.20 | 4987.00 |
| Sep 01, 2026 | 11.36 | 11.59 | 11.03 | 11.11 | 34509.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ProQR Therapeutics NV | 1.63 |
| NewAmsterdam Pharma Co. NV | 22.18 |
| argenx SE | 935.08 |
| Nektar Therapeutics | 39.46 |
| ACADIA Pharmaceuticals, Inc. | 19.61 |
Price Related Metrics
| PE Ratio | 77.88 |
| PS Ratio | 1.946 |
| Price to Book Value | 2.666 |
| Price to Free Cash Flow | 27.73 |
| Earnings Yield | 1.28% |
| Market Cap | 685.13M |
| Operating PE Ratio | 31.88 |
| Normalized PE Ratio | 43.45 |